Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

lab sign

Medimmune and Cancer Research UK launch new drug discovery lab

September 11, 2015 Research and Development AstraZeneca, Cambridge, Cancer, Cancer Research UK, MedImmune, R&D, george freeman

MedImmune and the UK’s biggest cancer charity have opened a new laboratory for joint cancer research.Research at the laboratory, which …
News
body scan

Pfizer in metabolic disease push

September 11, 2015 Medical Communications, Research and Development AMRA, Pfizer, UK Biobank, med tech, metabolic disease, obesity

Pfizer has signed a research collaboration with a global medical health technology company, to investigate risk factors for metabolic conditions.  …
News
zs-pharma-logo_cmyk

Actelion confirms takeover talks with ZS Pharma

September 11, 2015 Research and Development, Sales and Marketing Actelion, Shire, ZS Pharma, mergers and acquisitions

Swiss drugmaker Actelion has entered discussions with US biotech company ZS Pharma, over a takeover thought to be worth $2.5 …
News
john_jeans

EM Imaging appoints new chairman

September 10, 2015 Manufacturing and Production, Research and Development EM Imaging, Optometry, ophthalmology

The board of Edinburgh Molecular Imaging Ltd (EM Imaging) is pleased to announce the appointment of John Jeans as non-executive …
Appointment
Truvada pill

Gilead’s Truvada prevents HIV infections in high-risk men

September 10, 2015 Research and Development Gilead, HIV, PrEP, Truvada, pre-exposure prophylaxis treatment, sexually transmitted infections

UK researchers say Truvada, Gilead’s HIV prevention treatment, should be added to the country’s ‘HIV prevention toolkit’, after a study …
News
Westminster

Pharma leaders urge UK Government not to cut spending

September 9, 2015 Research and Development Autumn spending review, George Osborne, R&D, government, research, research and development, research funding

Representatives of more than 200 life sciences organisations have urged the UK government to protect the sector from spending cuts. …
News
Alzheimer's research

Neurimmune kicks off late-stage Alzheimer’s study

September 9, 2015 Research and Development Alzheimer's disease, Biogen, Neurimmune, aducanumab, neurology

Neurimmune and its development partner Biogen are beginning a Phase III study of the companies’ potential Alzheimer’s treatment aducanumab.  The …
News
asthma inhalers

GSK suffers Breo late-stage trial blow

September 9, 2015 Research and Development COPD, GSK, Revlar, asthma, breo, clinical trial, phase III

GSK has hit a setback in its plans to expand sales of its blockbuster asthma treatment Breo, after a major …
News
michael_koslowski_picture

Mission Therapeutics appoints new chief medical officer

September 9, 2015 Medical Communications, Research and Development Dr Michael Koslowski, Mission Therapeutics

Mission Therapeutics has announced the appointment of Dr Michael Koslowski as chief medical officer. Dr Koslowski brings over 15 years’ …
Appointment
unisa_research_building

Yabao Pharmaceutical and UniSA embark on joint venture

September 9, 2015 Research and Development Cancer, Yabao Pharmaceutical

Yabao Pharmaceutical and the University of South Australia (UniSA) have joined together in a collaboration to develop new treatments for …
News
avastin

New treatment option for ovarian cancer patients in Scotland

September 8, 2015 Medical Communications, Research and Development, Sales and Marketing Roche, Scotland, avastin, ovarian cancer

The Scottish Medicines Consortium (SMC) has approved the use of Avastin in combination with paclitaxel chemotherapy as a treatment for women …
News
Europe flag

EMA launches project to boost early patient access to drugs

September 8, 2015 Research and Development EMA, European Medicines Agency, MAPPs, adaptive pathways, drug development, market access

The EMA is launching an adaptive pathway project to bring new medicinal products to market in Europe.  The ADAPT SMART …
News
novo_nordisk_new_hillerod_facility

Novo Nordisk expands in Denmark

September 8, 2015 Manufacturing and Production, Research and Development Denmark, Novo Nordisk, haemophilia API

Novo Nordisk has announced that the company is investing 500 million Danish kroner (about £48.8 million) in a new 19,000 …
News
massachusetts_institute_of_technology_7194419730

Novo joins forces with MIT innovating drug devices

September 8, 2015 Manufacturing and Production, Research and Development Novo Nordisk

Novo Nordisk has initiated a research collaboration with the Langer Laboratory at the Massachusetts Institute of Technology for what is …
News
keytruda

NICE recommends Keytruda for advanced skin cancer

September 7, 2015 Research and Development, Sales and Marketing Merck, NICE, keytruda, skin cancer

NICE has approved Merck’s Keytruda (pembrolizumab) as a treatment for advanced skin cancer in final draft guidance for the NHS.  …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026